We are live on ! Find out more
DOFI

DCVC Opportunity Fund II Portfolio holdings

AUM $13.9M
1-Year Est. Return 8.04%
This Fund
S&P 500
This Quarter Est. Return
-16.47%
1 Year Est. Return
+8.04%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$16.6M
AUM Growth
-$2.69M
Cap. Flow
+$534K
Cap. Flow %
3.22%
Top 10 Hldgs %
100%
Holding
2
New
1
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
IONQ icon
IonQ
IONQ
+$534K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 97.42%
2 Technology 2.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RXRX icon
1
Recursion Pharmaceuticals
RXRX
$1.53B
$16.2M 97.42%
3,951,141
IONQ icon
2
IonQ
IONQ
$12.8B
$427K 2.58%
+9,521
New +$534K

Similar funds

DCVC Opportunity Fund II's Q4 2025 Portfolio in Review

As of Q4 2025, DCVC Opportunity Fund II held 2 positions worth $16.6M, down 14% from $19.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

DCVC Opportunity Fund II deployed $534K of net new capital in Q4 2025, opening 1 new position. Its largest new stake was IonQ: 9,521 shares worth $427K.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, down from 100% a quarter earlier, followed by Technology.

  • DCVC Opportunity Fund II's largest Q4 2025 buy was IonQ: 9,521 shares worth $427K.
  • DCVC Opportunity Fund II's ten largest holdings make up 100% of its $16.6M portfolio in Q4 2025.
  • DCVC Opportunity Fund II opened 1 new position and closed 0 in Q4 2025.
  • DCVC Opportunity Fund II's portfolio value fell 14% quarter-over-quarter to $16.6M.

Based on DCVC Opportunity Fund II's 13F filing for Q4 2025, filed 17 Feb 2026.